Seeking AlphaCodex · 实盘不做把握 8/10
北京时间·🕒 发布 07-22 23:49:16时区推断·⟳ 抓取 07-22 23:55:05·⚡ 决策 07-23 00:03:10 +8m05s·97.1 天前
NovoCure将于7月23日盘前发布二季度业绩，当前仅为财报预告
该信号只是Seeking Alpha对既定财报发布时间、市场一致预期和历史超预期比例的日历提醒，没有披露新增业绩结果、指引或公司级实质变化。
📄 原文Seeking Alpha↗ 原文
NovoCure Q2 2026 Earnings Preview
- NovoCure (NVCR) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open. - The consen…
不做 NovoCure（NVCR.US）
仅为财报前瞻和一致预期日历提醒，没有新增业绩结果、指引修正或可验证surprise，当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 medium · price-in 风险 high ↗
关键理由
- 该信号只是Seeking Alpha对既定财报发布时间、市场一致预期和历史超预期比例的日历提醒，没有披露新增业绩结果、指引或公司级实质变化。
主要风险
- 真正可交易的信息需等7月23日盘前财报实际数据、管理层指引及股价反应出现后重新研判。
原文全文
展开原文 · 473 字
- NovoCure (NVCR) is scheduled to announce Q2 earnings results on Thursday, July 23rd, before market open.
- The consensus EPS Estimate is -$0.33 and the consensus Revenue Estimate is $172.44M (+8.6% Y/Y).
- Over the last 1 year, NVCR has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 2 downward. Revenue estimates have seen 4 upward revisions and 3 downward.
- The consensus EPS Estimate is -$0.33 and the consensus Revenue Estimate is $172.44M (+8.6% Y/Y).
- Over the last 1 year, NVCR has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 2 downward. Revenue estimates have seen 4 upward revisions and 3 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。